Introduction Infants too young to be fully immunized are the most vulnerable to severe
pertussis disease. To close this susceptibility gap, passive infant immunization through …

As we live through the history-making pandemic of coronavirus disease 2019 (COVID-19), it
is timely to consider the lessons that history has taught us about vaccine-preventable …

Background Immunization of pregnant women with tetanus-diphtheria-acellular pertussis
vaccine (Tdap) provides protection against pertussis to the newborn infant. Methods In a …

At the start of 2022, profound inequities in the pace of access to COVID-19 vaccines and the
level of coverage of COVID-19 vaccination remain, especially with regard to the world's …

Introduction Bordetella pertussis still circulates worldwide despite vaccination. Fimbriae are
components of some acellular pertussis vaccines. Population fluctuations of B. pertussis …

In infants, Bordetella pertussis can cause severe disease, manifested as pronounced
leukocytosis, pulmonary hypertension, and even death. The exact cause of death remains …

Abstract Background In 2011, Argentina experienced its highest pertussis incidence and
mortality rates of the last decade; 60% of deaths were among infants aged< 2 months. In …

Objective Severe pertussis infection has been reported in infants before receiving routine
immunization series. This problem could be solved by vaccinating mothers during …

Bordetella pertussis causes pertussis (or whooping cough), a severe respiratory infectious
disease in infants, although it can be prevented by whole cell and acellular vaccines. The …

Importance An alternative option to maternal vaccination to prevent severe pertussis in
infants is vaccination at birth. Data are needed on the immunogenicity and safety of a birth …